Literature DB >> 25636729

[Epidemiology of brain metastases].

S Taillibert1, É Le Rhun2.   

Abstract

The most frequent intracranial brain tumours are brain metastases. All types of cancer can develop brain metastases but two thirds of brain metastases occurring in adult patients are secondary to one of these three cancers: lung cancer, breast cancer and melanoma. In accordance with these data, this review is focusing on the epidemiology of these three types of cancer. We report here the incidence, risk factors, median time of brain metastases occurrence after diagnosis of the primary cancer, prognosis and median survival for these three types of cancer. We also discuss the clinical implications of these data. The second part of this review is focusing on the Graded Prognostic Assessment scores in all types of primary cancer with brain metastases, how they can be applied in clinical research for a better stratification of patients, and to some extent in clinical practice to guide decisions for personalized treatments. These scores provide a better understanding of the different profiles of clinical evolution that can be observed amongst patients suffering from brain metastases according to the type of primary cancer. We highlighted the most remarkable and useful clinical implications of these data.
Copyright © 2015 Société française de radiothérapie oncologique (SFRO). Published by Elsevier SAS. All rights reserved.

Entities:  

Keywords:  Brain metastases; Epidemiology; Facteurs de risque; Facteurs pronostiques; GPA score; Métastases cérébrales; Prognostic factors; Risk factors; Score DS-GPA; Épidémiologie

Mesh:

Year:  2015        PMID: 25636729     DOI: 10.1016/j.canrad.2014.11.001

Source DB:  PubMed          Journal:  Cancer Radiother        ISSN: 1278-3218            Impact factor:   1.018


  25 in total

1.  High probability and frequency of EGFR mutations in non-small cell lung cancer with brain metastases.

Authors:  Mengxi Ge; Yingjie Zhuang; Xinli Zhou; Ruofan Huang; Xiaohua Liang; Qiong Zhan
Journal:  J Neurooncol       Date:  2017-08-05       Impact factor: 4.130

2.  Beyond an Updated Graded Prognostic Assessment (Breast GPA): A Prognostic Index and Trends in Treatment and Survival in Breast Cancer Brain Metastases From 1985 to Today.

Authors:  Paul W Sperduto; Shane Mesko; Jing Li; Daniel Cagney; Ayal Aizer; Nancy U Lin; Eric Nesbit; Tim J Kruser; Jason Chan; Steve Braunstein; Jessica Lee; John P Kirkpatrick; Will Breen; Paul D Brown; Diana Shi; Helen A Shih; Hany Soliman; Arjun Sahgal; Ryan Shanley; William Sperduto; Emil Lou; Ashlyn Everett; Drexell Hunter Boggs; Laura Masucci; David Roberge; Jill Remick; Kristin Plichta; John M Buatti; Supriya Jain; Laurie E Gaspar; Cheng-Chia Wu; Tony J C Wang; John Bryant; Michael Chuong; James Yu; Veronica Chiang; Toshimichi Nakano; Hidefumi Aoyama; Minesh P Mehta
Journal:  Int J Radiat Oncol Biol Phys       Date:  2020-02-19       Impact factor: 7.038

3.  Boost Irradiation Integrated to Whole Brain Radiotherapy in the Management of Brain Metastases.

Authors:  Ágnes Dobi; Emese Fodor; Anikó Maráz; Zsófia Együd; Adrienne Cserháti; László Tiszlavicz; Zita Reisz; Pál Barzó; Zoltán Varga; Katalin Hideghéty
Journal:  Pathol Oncol Res       Date:  2018-01-17       Impact factor: 3.201

4.  Gadolinium-Based Nanoparticles and Radiation Therapy for Multiple Brain Melanoma Metastases: Proof of Concept before Phase I Trial.

Authors:  Shady Kotb; Alexandre Detappe; François Lux; Florence Appaix; Emmanuel L Barbier; Vu-Long Tran; Marie Plissonneau; Hélène Gehan; Florence Lefranc; Claire Rodriguez-Lafrasse; Camille Verry; Ross Berbeco; Olivier Tillement; Lucie Sancey
Journal:  Theranostics       Date:  2016-01-20       Impact factor: 11.556

5.  EGFR and KRAS Mutations Predict the Incidence and Outcome of Brain Metastases in Non-Small Cell Lung Cancer.

Authors:  Pascale Tomasini; Cindy Serdjebi; Nataliya Khobta; Philippe Metellus; L'Houcine Ouafik; Isabelle Nanni; Laurent Greillier; Anderson Loundou; Frederic Fina; Celine Mascaux; Fabrice Barlesi
Journal:  Int J Mol Sci       Date:  2016-12-18       Impact factor: 5.923

Review 6.  Mechanisms and Therapy for Cancer Metastasis to the Brain.

Authors:  Federica Franchino; Roberta Rudà; Riccardo Soffietti
Journal:  Front Oncol       Date:  2018-05-24       Impact factor: 6.244

7.  Single isocenter SRS using CAVMAT offers improved robustness to commissioning and treatment delivery uncertainty compared to VMAT.

Authors:  Edward T Cullom; Yuqing Xia; Kai-Cheng Chuang; Zachary W Gude; Yana Zlateva; Justus D Adamson; William M Giles
Journal:  J Appl Clin Med Phys       Date:  2021-06-24       Impact factor: 2.102

8.  Distribution of metastatic disease in the brain in relation to the hippocampus: a retrospective single-center analysis of 6064 metastases in 632 patients.

Authors:  San-Gang Wu; Ming-Yue Rao; Juan Zhou; Qin Lin; Zi-Jing Wang; Yong-Xiong Chen; Zhen-Yu He
Journal:  Oncotarget       Date:  2015-12-22

Review 9.  [Association between EGFR, ALK and KRAS Gene Status and Synchronous Distant 
Organ Metastasis in Non-small Cell Lung Cancer].

Authors:  Ge Gao; LiLi Deng
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2018-07-20

10.  Brain metastases epidemiology in a Tunisian population: trends and outcome.

Authors:  Mehdi Benna; Nesrine Mejri; Manel Mabrouk; Houda El Benna; Soumaya Labidi; Nouha Daoud; Hamouda Boussen
Journal:  CNS Oncol       Date:  2018-01-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.